321 filings
Page 3 of 17
6-K
ts8uin5u23 9a5em2utt
11 May 22
BELLUS Health Reports First Quarter 2022 Financial Results and Business Highlights
5:23pm
6-K
qtbm4
11 May 22
Condensed Consolidated Interim Financial Statements of
5:05pm
6-K
8apb9 aon
2 May 22
BELLUS Health to Present Late-Breaking Clinical Data from the Phase 2b SOOTHE Trial of BLU-5937 at the ATS 2022 International Conference
7:00am
6-K
e2158 nvg9
25 Apr 22
BELLUS Health to Participate in Multiple Upcoming Investor Conferences
4:02pm
6-K
up3nx
7 Apr 22
Notice of Annual Meeting of Shareholders
9:01am
6-K
1qw6rg dvs2vx3a087er
5 Apr 22
Current report (foreign)
4:07pm
6-K
5bols6lcpxriy nifi
4 Mar 22
Report of Foreign Private Issuer for the Month of March 2022
11:32am
6-K
rj1ap7b
1 Mar 22
BELLUS Health to Participate in the Cowen & Co. 42nd Annual Health Care Conference
7:00am
6-K
ougcu2apflky7o839zo
23 Feb 22
BELLUS Health Reports Year 2021 Financial Results and Business Highlights
4:01pm
6-K
c30 c4fet
17 Dec 21
BELLUS Health Closes US$200 Million Public Offering of Common Shares in Canada and the United States
4:03pm
6-K
aym8e8qhe24exta kcia
15 Dec 21
BELLUS Health Announces Pricing of US$200 Million Public Offering in Canada and the United States
5:15pm
6-K
5uo62wz5
13 Dec 21
BELLUS Health Announces the Launch of a Public Offering of Common Shares in Canada and the United States
4:07pm
6-K
v2fat8df 3781vni0ask
13 Dec 21
BELLUS Health Announces Positive Topline Results from its Phase 2b SOOTHE Trial of BLU-5937 for the Treatment of Refractory Chronic Cough
7:19am
6-K
ov7wllclmplhe
13 Dec 21
BELLUS Health Announces Positive Topline Results from its Phase 2b SOOTHE Trial of BLU-5937 for the Treatment of Refractory Chronic Cough
7:00am
6-K
kgrb 9b8haij
10 Nov 21
Condensed Consolidated Interim Financial Statements of
4:42pm
6-K
yba407
10 Nov 21
BELLUS Health Reports Third Quarter 2021 Financial Results and Business Highlights
4:30pm
6-K
4n9n n0rshg7usc2nd
10 Nov 21
BELLUS Health to Participate in Two Upcoming Healthcare Investor Conferences
7:00am
6-K
h0azna r1
1 Nov 21
Bellus Health Inc. 6-K
7:00am
6-K
4fnd1tqlv 18w6hfnvx
23 Sep 21
Topline results from both studies are expected in December 2021
7:00am
6-K
8tkgbobw3umlnv5h
13 Sep 21
BELLUS Health Announces Positive Interim Analysis from the Phase 2b SOOTHE Trial of BLU-5937 in Refractory Chronic Cough
7:45am